Erasca, Inc. (ERAS)
13.61
-0.61
(-4.29%)
USD |
NASDAQ |
Nov 20, 16:00
13.74
+0.13
(+0.96%)
After-Hours: 20:00
Erasca Shareholders Equity (Quarterly) : 916.74M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 916.74M |
| June 30, 2026 | 361.87M |
| March 31, 2026 | 393.53M |
| December 31, 2025 | 325.17M |
| September 30, 2025 | 347.89M |
| June 30, 2025 | 372.26M |
| March 31, 2025 | 399.50M |
| December 31, 2024 | 423.50M |
| September 30, 2024 | 450.04M |
| June 30, 2024 | 451.09M |
| March 31, 2024 | 288.41M |
| December 31, 2023 | 316.69M |
| Date | Value |
|---|---|
| September 30, 2023 | 338.98M |
| June 30, 2023 | 362.70M |
| March 31, 2023 | 386.45M |
| December 31, 2022 | 411.85M |
| September 30, 2022 | 365.32M |
| June 30, 2022 | 395.07M |
| March 31, 2022 | 424.66M |
| December 31, 2021 | 456.53M |
| September 30, 2021 | 482.99M |
| June 30, 2021 | 190.80M |
| March 31, 2021 | 211.54M |
| December 31, 2020 | 107.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 888.02M |
| Revolution Medicines, Inc. | 2.402B |
| Immunome, Inc. | 454.30M |
| Tango Therapeutics, Inc. | 980.17M |
| Oncolytics Biotech, Inc. | -7.503M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 998.94M |
| Total Liabilities (Quarterly) | 82.20M |
| Debt to Equity Ratio | 0.0473 |
| Current Ratio | 14.89 |
| Net Debt Paydown Yield | 0.02% |